Decatur Capital Management’s Edwards Lifesciences EW Stock Holding History

Decatur Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-177,150	Closed	-$10.3M	–	55
2018 Q3	$10.3M	Sell	177,150 -44,025	-20%	-$2.15M	2.37%	6
2018 Q2	$10.7M	Sell	221,175 -1,350	-0.6%	-$63K	2.13%	13
2018 Q1	$10.3M	Sell	222,525 -6,600	-3%	-$287K	2.13%	16
2017 Q4	$8.61M	Sell	229,125 -36,300	-14%	-$1.33M	1.74%	33
2017 Q3	$9.67M	Buy	265,425 +15,225	+6%	+$581K	1.85%	30
2017 Q2	$9.86M	Buy	+250,200	New	+$9.13M	2.07%	20
2013 Q4	–	Sell	-277,650	Closed	-$3.22M	–	98
2013 Q3	$3.22M	Buy	277,650 +179,400	+183%	+$2.1M	0.68%	63
2013 Q2	$1.1M	Buy	+98,250	New	+$1.16M	0.38%	67

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Decatur Capital Management's EW Position: Q4 2018 in Review

Decatur Capital Management sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 177,150 shares — an estimated $10.3M sold.

Decatur Capital Management first reported a position in EW in Q2 2013 and held it in 8 quarters. The position peaked at $10.7M in Q2 2018. 875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

Decatur Capital Management reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
Decatur Capital Management sold 177,150 Edwards Lifesciences shares in Q4 2018, an estimated $10.3M.
Decatur Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 8 quarters.
Decatur Capital Management's Edwards Lifesciences position peaked at $10.7M in Q2 2018.
875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Decatur Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.